CurveBeam AI (ASX:CVB) FCF Margin %: -127.49% (As of Dec. 2025)


What is CurveBeam AI FCF Margin %?

CurveBeam AI ASX:CVB -6.67% FCF Margin % is -127.49% as of Dec. 2025. The stock has 5 warning signs investors should review. Among 815 Medical Devices & Instruments companies, CurveBeam AI ranks worse than 83.68% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. CurveBeam AI's Free Cash Flow for the six months ended in Dec. 2025 was A$-6.33 Mil. CurveBeam AI's Revenue for the six months ended in Dec. 2025 was A$4.96 Mil. Therefore, CurveBeam AI's FCF Margin % for the quarter that ended in Dec. 2025 was -127.49%.

As of today, CurveBeam AI's current FCF Yield % is -77.12%.

The historical rank and industry rank for CurveBeam AI's FCF Margin % or its related term are showing as below:

ASX:CVB' s FCF Margin % Range Over the Past 10 Years
Min: -339.88   Med: -141.47   Max: -67.07
Current: -84.89

During the past 5 years, the highest FCF Margin % of CurveBeam AI was -67.07%. The lowest was -339.88%. And the median was -141.47%.

ASX:CVB's FCF Margin % is ranked worse than
83.68% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: -0.1 vs ASX:CVB: -84.89

CurveBeam AI FCF Margin % Related Terms

CurveBeam AI FCF Margin % Historical Data

* Premium members only.

The historical data trend for CurveBeam AI's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CurveBeam AI FCF Margin % Chart

CurveBeam AI Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
FCF Margin %
-67.07 -141.47 -279.53 -339.88 -96.38

CurveBeam AI Semi-Annual Data
Jun21 Dec21 Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only -373.23 -303.22 -156.30 -55.49 -127.49

ASX:CVB vs ABT, SYK, MDT: FCF Margin % Comparison

For the Medical Devices subindustry, CurveBeam AI's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CurveBeam AI FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CurveBeam AI's FCF Margin % distribution charts can be found below:

* The bar in red indicates where CurveBeam AI's FCF Margin % falls into.


CurveBeam AI FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

CurveBeam AI's FCF Margin for the fiscal year that ended in Jun. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-11.659/12.097
=-96.38 %

CurveBeam AI's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-6.326/4.962
=-127.49 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -127.49% mean?
CurveBeam AI (ASX:CVB) has a FCF Margin % of -127.49% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on CurveBeam AI and its competitors. According to the industry distribution chart, CurveBeam AI ranks #682 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 83.7%.
Is CurveBeam AI's FCF Margin % too high?
CurveBeam AI's current FCF Margin % is -127.49%. Based on the distribution chart, CurveBeam AI ranks #682 out of 815 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does CurveBeam AI's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, CurveBeam AI ranks #682 out of 815 companies for FCF Margin %. This places CurveBeam AI in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on CurveBeam AI and its competitors. CurveBeam AI's current FCF Margin % is -127.49%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CurveBeam AI stock overvalued right now?
CurveBeam AI (ASX:CVB) has a current FCF Margin % of -127.49%. The current FCF Margin % is -127.49%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For CurveBeam AI (ASX:CVB), the current FCF Margin % is -127.49% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CurveBeam AI Business Description

Address 10 Queen Street, Level 10, Melbourne, VIC, AUS, 3000
CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the company's CT devices to assist in the clinical assessment. The company has one operating segment, being the research, design, manufacture and sale of cone beam CT imaging equipment for orthopaedic specialties, which includes the development, validation and preparation for commercialisation of a HRpQCT Medical Device and Software as a Service (SaaS) platform.